Skip to main content

Advertisement

SpringerLink
Log in

Serotonin receptor 2A blocker (risperidone) has no effect on human polyomavirus JC infection of primary human fetal glial cells

  • Short Communication
  • Published:
Journal of NeuroVirology Aims and scope Submit manuscript

Abstract

A recent report demonstrated that JC virus (JCV) employs serotonin receptor 2A (5HT2AR) to infect the glial cells. To assess the ability of a potent 5HT2AR blocker, risperidone, to inhibit JCV infection, the authors treated primary human fetal glial (PHFG) cells in vitro with risperidone for 24 h and inoculated with JCV(Mad1). There was no significant difference in JCV genome copies or mRNA transcripts and protein expression in treatment-naïve and risperidone-treated PHFG cells. These data indicate that risperidone does not inhibit JCV(Mad1) attachment, internalisation, and replication in PHFG cells, and 5HT2AR blockers may not be effective in treating progressive multifocal leukoencephalopathy (PML).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Agostini HT, Deckhut A, Jobes DV, Girones R, Schlunck G, Prost MG, Frias C, Perez-Trallero E, Ryschkewitsch CF, Stoner GL (2001). Genotypes of JC virus in East, Central and Southwest Europe. J Gen Virol 82: 1221–331.

    PubMed  CAS  Google Scholar 

  • Agostini HT, Ryschkewitsch CF, Singer EJ, Stoner GL (1997). JC virus regulatory region rearrangements and genotypes in progressive multifocal leukoencephalopathy: two independent aspects of virus variation. J Gen Virol 78(Pt 3): 659–664.

    PubMed  CAS  Google Scholar 

  • Agostini HT, Ryschkewitsch CF, Stoner GL (1996). Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals. J Clin Microbiol 34: 159–164.

    PubMed  CAS  Google Scholar 

  • Aksamit AJ (2001). Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside. J NeuroVirol 7: 386–390.

    Article  PubMed  CAS  Google Scholar 

  • Altschuler EL, Kast RE (2005). The atypical antipsychotic agents ziprasidone [correction of zisprasidone], risperdone and olanzapine as treatment for and prophylaxis against progressive multifocal leukoencephalopathy. Med Hypotheses 65: 585–586.

    Article  PubMed  CAS  Google Scholar 

  • Antinori A, Ammassari A, Giancola ML, Cingolani A, Grisetti S, Murri R, Alba L, Ciancio B, Soldani F, Larussa D, Ippolito G, De Luca A (2001). Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era. J NeuroVirol 7: 323–328.

    Article  PubMed  CAS  Google Scholar 

  • Antinori A, Cingolani A, Lorenzini P, Giancola ML, Uccella I, Bossolasco S, Grisetti S, Moretti F, Vigo B, Bongiovanni M, Del Grosso B, Arcidiacono MI, Fibbia GC, Mena M, Finazzi MG, Guaraldi G, Ammassari A, d’Arminio Monforte A, Cinque P, De Luca A (2003). Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J NeuroVirol 9(Suppl 1): 47–53.

    PubMed  CAS  Google Scholar 

  • Chapagain ML, Nguyen T, Bui T, Verma S, Nerurkar VR (2006). Comparison of real-time PCR and hemagglutination assay for quantitation of human polyomavirus JC. Virol J 3: 3. Please see http://www.virologyj.com/content/3/1/3.

    Article  PubMed  Google Scholar 

  • Chapagain ML, Verma S, Mercier F, Yanagihara R, Nerurkar VR (2007). Polyomavirus JC infects human brain microvascular endothelial cells independent of serotonin receptor 2A. Virology 364: 55–63.

    Article  PubMed  CAS  Google Scholar 

  • Co JK, Verma S, Gurjav U, Sumibcay L, Nerurkar VR (2007). Interferon-alpha and-beta restrict polyomavirus JC replication in primary human fetal glial cells: implications for progressive multifocal leukoencephalopathy therapy. J Infect Dis 196: 712–718.

    Article  PubMed  CAS  Google Scholar 

  • Colosimo C, Lebon P, Martelli M, Tumminelli F, Mandelli F (1992). Alpha-interferon therapy in a case of probable progressive multifocal leukoencephalopathy. Acta Neurol Belg 92: 24–29.

    PubMed  CAS  Google Scholar 

  • De Luca A, Giancola ML, Ammassari A, Grisetti S, Cingolani A, Larussa D, Alba L, Murri R, Ippolito G, Cauda R, Monforte A, Antinori A (2001). Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: extended follow-up of an observational study. J NeuroVirol 7: 364–368.

    Article  PubMed  Google Scholar 

  • De Luca A, Giancola ML, Cingolani A, Ammassari A, Gillini L, Murri R, Antinori A (1999). Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy. Clin Infect Dis 28: 624–628.

    Article  PubMed  Google Scholar 

  • Decker M, Schleifer KJ, Nieger M, Lehmann J (2004). Dopamine/serotonin receptor ligands. Part VIII: The dopamine receptor antagonist LE300—modelled and X-ray structure plus further pharmacological characterization, including serotonin receptor binding, biogenic amine transporter testing and in vivo testings. Eur J Med Chem 39: 481–489.

    Article  PubMed  CAS  Google Scholar 

  • Dubois V, Moret H, Lafon ME, Brodard V, Icart J, Ruffault A, Guist’hau O, Buffet-Janvresse C, Abbed K, Dussaix E, Ingrand D (2001). JC virus genotypes in France: molecular epidemiology and potential significance for progressive multifocal leukoencephalopathy. J Infect Dis 183: 213–217.

    Article  PubMed  CAS  Google Scholar 

  • Elphick GF, Querbes W, Jordan JA, Gee GV, Eash S, Manley K, Dugan A, Stanifer M, Bhatnagar A, Kroeze WK, Roth BL, Atwood WJ (2004). The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306: 1380–1383.

    Article  PubMed  CAS  Google Scholar 

  • Enting RH, Portegies P (2000). Cytarabine and highly active antiretroviral therapy in HIV-related progressive multifocal leukoencephalopathy. J Neurol 247: 134–138.

    Article  PubMed  CAS  Google Scholar 

  • Focosi D, Fazzi R, Montanaro D, Emdin M, Petrini M (2007). Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipient: a clinical, neuroradiological and virological response after treatment with risperidone. Antiviral Res 74: 156–158.

    Article  PubMed  CAS  Google Scholar 

  • Focosi D, Kast RE, Maggi F, Ceccherini-Nelli L, Petrini M (2007b). Risperidone-induced reduction in JC viruria as a surrogate marker for efficacy against progressive multifocal leukoencephalopathy and hemorrhagic cystitis. J Clin Virol 39: 63–64.

    Article  PubMed  CAS  Google Scholar 

  • Geschwind MD, Skolasky RI, Royal WS, McArthur JC (2001). The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS. J NeuroVirol 7: 353–357.

    Article  PubMed  CAS  Google Scholar 

  • Huang SS, Skolasky RL, Dal Pan GJ, Royal W, 3rd, McArthur JC (1998). Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-interferon: an observational study. J NeuroVirol 4: 324–332.

    Article  PubMed  CAS  Google Scholar 

  • Lima MA, Katz-Brull R, Lenkinski RE, Nunez R, Feinrider D, Koralnik IJ (2007). Remission of progressive multifocal leukoencephalopathy and primary central nervous system lymphoma in an HIV-infected patient. Eur J Neurol 14: 598–602.

    Article  PubMed  CAS  Google Scholar 

  • Marra CM, Rajicic N, Barker DE, Cohen BA, Clifford D, Donovan Post MJ, Ruiz A, Bowen BC, Huang ML, Queen-Baker J, Andersen J, Kelly S, Shriver S (2002). A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. AIDS 16: 1791–1797.

    Article  PubMed  CAS  Google Scholar 

  • Maxishima M, Shiga T, Shutoh F, Hamada S, Maeshima T, Okado N (2001). Serotonin 2A receptor-like immunoreactivity is detected in astrocytes but not in oligodendrocytes of rat spinal cord. Brain Res 889: 270–273.

    Article  PubMed  CAS  Google Scholar 

  • Morisset S, Sahm UG, Traiffort E, Tardivel-Lacombe J, Arrang JM, Schwartz JC (1999). Atypical neuroleptics enhance histamine turnover in brain via 5-Hydroxytryptamine2A receptor blockade. J Pharmacol Exp Ther 288: 590–596.

    PubMed  CAS  Google Scholar 

  • Nath A, Venkataramana A, Reich DS, Cortese I, Major EO (2006). Progression of progressive multifocal leukoencephalopathy despite treatment with beta-interferon. Neurology 66: 149–150.

    Article  PubMed  CAS  Google Scholar 

  • O’Hara BA, Atwood WJ (2008). Interferon beta1-a and selective anti-5HT(2a) receptor antagonists inhibit infection of human glial cells by JC virus. Virus Res 132: 97–103.

    Article  PubMed  Google Scholar 

  • Owczarczyk K, Hilker R, Brunn A, Hallek M, Rubbert A (2007). Progressive multifocal leucoencephalopathy in a patient with sarcoidosis—successful treatment with cidofovir and mirtazapine. Rheumatology (Oxford) 46: 888–890.

    Article  CAS  Google Scholar 

  • Padgett BL, Rogers CM, Walker DL (1977). JC virus, a human polyomavirus associated with progressive multifocal leukoencephalopathy: additional biological characteristics and antigenic relationships. Infect Immun 15: 656–662.

    PubMed  CAS  Google Scholar 

  • Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH (1971). Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1: 1257–1260.

    Article  PubMed  CAS  Google Scholar 

  • Santagata S, Kinney HC (2005). Mechanism of JCV entry into oligodendrocytes. Science 309: 381–382.

    Article  PubMed  CAS  Google Scholar 

  • Shah KV, Daniel RW, Strickler HD, Goedert JJ (1997). Investigation of human urine for genomic sequences of the primate polyomaviruses simian virus 40, BK virus, and JC virus. J Infect Dis 176: 1618–1621.

    Article  PubMed  CAS  Google Scholar 

  • Verma S, Cikurel K, Koralnik IJ, Morgello S, Cunningham-Rundles C, Weinstein ZR, Bergmann C, Simpson DM (2007). Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. J Infect Dis 196: 709–711.

    Article  PubMed  CAS  Google Scholar 

  • Vulliemoz S, Lurati-Ruiz F, Borruat FX, Delavelle J, Koralnik IJ, Kuntzer T, Bogousslavsky J, Picard F, Landis T, Du Pasquier RA (2006). Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. J Neurol Neurosurg Psychiatry 77: 1079–1082.

    Article  PubMed  CAS  Google Scholar 

  • Wyen C, Hoffmann C, Schmeisser N, Wohrmann A, Qurishi N, Rockstroh J, Esser S, Rieke A, Ross B, Lorenzen T, Schmitz K, Stenzel W, Salzberger B, Fatkenheuer G (2004). Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death. J Acquir Immune Defic Syndr 37: 1263–1268.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Retrovirology Research Laboratory, Department of Tropical Medicine, Medical Microbiology and Pharmacology, Asia-Pacific Institute of Tropical Medicine and Infectious Diseases, John A. Burns School of Medicine, Honolulu, Hawaii, USA

    Moti L. Chapagain, Laarni Sumibcay, Ulziijargal Gurjav, Pakieli H. Kaufusi & Vivek R. Nerurkar

  2. Molecular Biosciences and Bioengineering Graduate Program, College of Tropical Agriculture and Human Resources, University of Hawaii at Manoa, Honolulu, Hawaii, USA

    Ulziijargal Gurjav & Vivek R. Nerurkar

  3. Department of Psychiatry, University of Vermont, Burlington, Vermont, USA

    Richard E. Kast

Authors
  1. Moti L. Chapagain
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laarni Sumibcay
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ulziijargal Gurjav
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pakieli H. Kaufusi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Richard E. Kast
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Vivek R. Nerurkar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vivek R. Nerurkar.

Additional information

This work was supported by U.S. Public Health Service grants from the Collaborative Neurological Sciences Program (S11 NS041833) and the Specialized Neurosciences Research Program (U54 NS039406), National Institute of Neurological Disorders and Stroke, as well as from the Research Centers in Minority Institutions Program (G12 RR003061) and Centers of Biomedical Research Excellence (P20 RR018727), National Center for Research Resources, National Institutes of Health.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chapagain, M.L., Sumibcay, L., Gurjav, U. et al. Serotonin receptor 2A blocker (risperidone) has no effect on human polyomavirus JC infection of primary human fetal glial cells. Journal of NeuroVirology 14, 448–454 (2008). https://doi.org/10.1080/13550280802235916

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1080/13550280802235916

Keywords

Search

Navigation